News
Oscar Health shares dip as Centene withdraws 2025 guidance citing elevated market morbidity; Oscar reaffirms its full-year outlook after Q1 beat.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback